| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Clayton Trier last filed a Form 4 in May 2025, as Director at USPH. Clayton Trier's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Clayton Trier's trades have earned a middling insider score of 66/100 across 9 rated trades. Over a 12-month horizon, 77.8% of those trades were profitable, with an average 12-month return of +7.8%.
At the last filing, the largest reported position was 8,306 shares of USPH. The USPH filings lean toward selling, a net 26,380 shares.
Clayton Trier has 25 Form 4 filings on record from March 2015 to May 2025, all as Director at U S Physical Therapy (USPH), 2015–2025.
The 30 reported transactions were 16 open-market sales, 11 stock awards and 3 gifts.
Counted by filing, the open-market trades come to no purchases and 12 sales worth about $2.3M.
The largest open-market sale was 3,750 shares of USPH at an average $135.19 on August 13, 2019, about $507K.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from May 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2024 | USPH U S Physical Therapy Inc /nv | Director | Sell | 2,000 | $95.78 | $191,560.00 | -23.7% | -7.7% | -22.3% | |
| Mar 13, 2024 | USPH U S Physical Therapy Inc /nv | Director | Sell | 400 | $107.00 | $42,800.00 | -5.4% | -11.7% | -28.5% | |
| Dec 13, 2023 | USPH U S Physical Therapy Inc /nv | Director | Sell | 1,170 | $92.26 | $107,944.20 | -13.7% | +14.3% | +1.1% | |
| Mar 3, 2023 | USPH U S Physical Therapy Inc /nv | Director | Sell | 370 | $102.69 | $37,995.30 | -4.7% | +0.1% | +1.7% | |
| Dec 2, 2022 | USPH U S Physical Therapy Inc /nv | Director | Sell | 2,740 | $88.48 | $242,430.60 | -25.9% | +11.2% | -3.5% | |
| Jun 3, 2021 | USPH U S Physical Therapy Inc /nv | Director | Sell | 2,500 | $119.91 | $299,784.61 | -21.8% | -2.5% | -6.9% | |
| May 26, 2021 | USPH U S Physical Therapy Inc /nv | Director | Sell | 200 | $120.30 | $24,060.00 | -1.7% | -5.2% | -5.4% | |
| Aug 13, 2019 | USPH U S Physical Therapy Inc /nv | Director | Sell | 3,750 | $135.19 | $506,962.50 | -27.1% | - | - | |
| Aug 17, 2018 | USPH U S Physical Therapy Inc /nv | Director | Sell | 1,250 | $115.50 | $144,375.00 | -9.3% | - | - | |
| Dec 12, 2017 | USPH U S Physical Therapy Inc /nv | Director | Sell | 4,250 | $71.97 | $305,872.50 | -27.0% | - | - |